Accu-Base Hemoglobin A1C Sample Collection Kit
Assay, Glycosylated Hemoglobin. 510(k) K013465, from Diabetes Technologies, Inc. (Thomasville, GA). Product code LCP, class 2.
As of Nov 22, 2026, K013465 is an FDA 510(k) held by Diabetes Technologies, Inc., substantially equivalent on Jan 22, 2002 after 96 days, with no recalls tied to it in FDA's recall database.
- Review time: 96 days
- Recalls: 0
K013465 AccuBase A1c Test Kit The intended use of the AccuBase A1c Test Kit is for the determination of the relative percent (%) A1c (glycohemoglobin) in human whole blood (capillary) samples, using high performance liquid chromatography (HPLC) as the analytical method.
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Type
- Traditional
- Received
- Oct 18, 2001
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files